Saturday Dec 12 | TheStreet.com
Glaxo, Wyeth Cut Costs With Trial Software
With the click of a mouse, pharmaceutical companies including GlaxoSmithKline and Wyeth save billions of dollars running clinical drug trials using software from DecisionView , a San Francisco-based startup.
SEC eyes 9 deals in insider trading probe: report
Jeffrey Kindler , Chairman and CEO of Pfizer, and Bernard Poussot, Chairman and CEO of Wyeth, speak during a news conference announcing the merger of the two companies in New York in this January 26, 2009 file photo.
Earnings Watch: Updates, advisories and surprises
Pfizer Inc. /quotes/comstock/13*!pfe /quotes/nls/pfe Chief Executive Officer Jeffrey Kindler told reporters at a luncheon in Boston Tuesday that he would not comment on whether the company will raise its once-coveted dividend.
Daniel Loeb Top Holdings: PHH, CF, LIA, BAC, BPOP
Third Point's Daniel Loeb had a good third quarter and YTD this year. His Third Point Offshore Fund returned 19.8% for the third quarter of 2009 and 27.6% for the first nine months, beating the S&P 500 by a large margin in both cases.
Zeroing In On What's Important
Pfizer's Amy Schulman on how she makes the most of every minute. As general counsel of Pfizer , the world's largest research-based pharmaceutical company, Amy Schulman crams more into a day than most managers get done in a week.
Wyeth hit with $75 million verdict
A Philadelphia jury has ordered Wyeth Pharmaceuticals to pay a woman $75 million in punitive damages after finding a link between her breast cancer and a hormone-replacement drug.
South Brunswick loses Wall Street Journal, Pfizer in one-week span
Last week, Dow Jones announced it was closing its Wall Street Journal printing plant in South Brunswick, a move that will slash about 55 jobs.
Bacteria warning prompts HEB to pull baby formula
H.E. Butt Grocery Co. has removed HEB brand milk- and soy-based powdered baby formula from its shelves as a precautionary measure, the company announced.
Progenics Reports Q3 2009 Financial Results
Progenics Pharmaceuticals, Inc. announced its results of operations for the third quarter and nine months ended September 30, 2009.
Pfizer lists realigned operations
Less than a month after buying Wyeth, drug giant Pfizer Inc. has mapped out a new structure for its research and development operations.
Merck CEO Richard Clark says company plans to keep N.J. research facilities
In a 2005 file photo Richard T. Clark, CEO & President, Merck & Co., speaks during an interview at the corporate headquarters in Whitehouse Station.
Pfizer Unveils Shiny New "Leaping" Logo
Pfizer , fresh from consummating its merger with Wyeth , has unveiled a new logo.
Flamel Technologies Announces Licensing Agreement with Pfizer Inc.
Flamel Technologies today announced that Pfizer has exercised its option to license Flamela s MedusaA technology for the development of a controlled release formulation of an already-marketed therapeutic protein.
P&G explores divestment, acquisition options
Declining sales have pushed Robert McDonald, the new chief executive of US consumer goods giant Procter & Gamble , to look for acquisitions and divestments, The Wall Street Journal writes Thursday citing informed sources.
Pfizer returns to consumer care with Wyeth buy
NEW YORK The approval last week of the Wyeth acquisition by Pfizer marks the return of a consumer-care division to Pfizer, and a considerable one at that.
This Partnership Will Go No Further
Progenics Pharmaceuticals ' constipation reliever, Relistor, is a good drug that not enough people want.
Pfizer profit jumps 26 percent on cost cuts
Pfizer Inc. today posted a higher third-quarter profit despite the recession, as sharp cost cuts made up for a dip in sales.
Pfizer will close Fort Dodge's 200-employee office in OP
Pfizer said Tuesday that it will discontinue Fort Dodge Animal Health 's Overland Park operations, which it took on as part of its acquisition of Wyeth .
Antitrust issues in the U.S. and Canada done, There's nothing left to do. Pfizer wed its bride Wyeth today, And to that I say: "Boo-hoo." The ticker will be gone -- oh WYE? WYE? WYE? Not even a hyphenated name will remain.
Madison welcomes Pfizer to Wyeth site
Pfizer's offices will be known collectively as "The Leadership Center for Pfizer Diversified Businesses.'' The name reflects the variety of businesses that will be located on the campus, including animal health as well as nutrition and consumer products -- divisions the company gained from Wyeth.
Also on Topix